Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

UK Authorities Crack Down on Fake Weight-Loss Medicine Factory Linked to Mounjaro

UK Authorities Crack Down on Fake Weight-Loss Medicine Factory Linked to Mounjaro

Post by : Rameen Ariff

The UK has made a significant breakthrough by uncovering the world's most substantial cache of unregulated weight-loss medicines, taking down an illicit operation that produced hazardous injections falsely advertised as containing Eli Lilly's Mounjaro and Zepbound. This groundbreaking raid, confirmed by the Medicines and Healthcare products Regulatory Agency (MHRA) on Friday, represents a historic first in the UK.

Authorities confiscated 2,000 injection pens claiming to include tirzepatide—the active ingredient in Eli Lilly’s acclaimed weight-loss drug Mounjaro—and retatrutide, an experimental treatment still undergoing clinical trials. Additional materials, including tens of thousands of empty pens and raw substances, were seized from this illegal facility.

Eli Lilly commended the MHRA for its decisive actions, emphasizing it as “a powerful blow against criminal syndicates endangering lives through counterfeit weight-loss injections.” The pharmaceutical company cautioned that individuals acquiring unregulated weight-loss drugs online or from underground markets cannot ascertain the true contents of these products, posing serious health risks.

Health Minister Wes Streeting described the seizure as “a triumph in battling unscrupulous criminals who jeopardize lives by marketing unsafe and illegal weight-loss injections.” He noted that these unregulated drugs are produced without safety checks, placing unwary purchasers at significant risk.

Tirzepatide and retatrutide act similarly to natural hormones that suppress appetite and manage blood glucose levels, yet both are tightly controlled in the UK. The National Health Service provides these medications only to patients meeting stringent medical criteria, while private treatments can incur costs of hundreds of pounds each month.

This operation underscores an escalating global issue regarding counterfeit and unregulated weight-loss drugs. In the U.S., some have sought to acquire raw components online to concoct DIY GLP-1-based injections, such as semaglutide marketed as Ozempic and Wegovy, prompted by skyrocketing costs and restricted access. Experts alert that these homemade weight-loss solutions pose grave health dangers, including potential contamination, improper dosing, and absence of medical supervision.

This landmark seizure communicates a crucial message from UK authorities: purchasing counterfeit or illicit weight-loss medicines not only violates the law but could also be life-threatening. Regulators persistently encourage the community to shun unlicensed products and to consider safe, approved weight-loss treatments administered under professional guidance.

Oct. 25, 2025 5:10 p.m. 2332

#Global

Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Najib Razak Leaves Prison to Serve Remaining Sentence at Home
Nov. 6, 2026 2:22 p.m.
Najib Razak leaves Kajang Prison after payment of a RM50 million fine, allowing Malaysia's former PM to serve his remaining sentence at home
Read More
Singapore Warns Users About Privacy and Security Risks of AI Agents
Nov. 6, 2026 12:50 p.m.
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised access to personal accounts
Read More
Trending News